期刊文献+

醒脾开郁方对抑郁症大鼠模型的中枢单胺类递质的影响 被引量:20

Effect of Xinpikaiyu Formula on central monoamine neurotransmitters in rat model of depression
原文传递
导出
摘要 目的研究醒脾开郁方对抑郁症大鼠模型海马及皮层的单胺类递质的影响。方法结合分养及慢性不可预见性应激的方法造成大鼠抑郁模型,应用高效液相色谱-电化学检测器观察大鼠海马及皮层单胺类递质和其代谢产物的变化,以探讨醒脾开郁方抗抑郁的机制。结果模型组大鼠海马及皮层5-羟色胺(5-HT)含量明显低于正常组,海马3,4二羟基苯乙酸(DOPAC)、高香草酸(HVA)、DOPAC/多巴胺(DA)、5-羟吲哚乙酸(5HIAA)/5-羟色胺(5-HT)及皮层5-HIAA/5-HT均明显高于正常组。醒脾开郁方可明显升高慢性应激抑郁模型大鼠海马及皮层5-HT,降低海马DOPAC、HVA含量,并降低海马DOPAC/DA、5-HIAA/5HT和皮层5-HIAA/5-HT。结论提示醒脾开郁方通过降低海马和皮层5-HT及DA的代谢,相对升高海马5HT、DA及皮层5-HT含量而发挥抗抑郁作用。 Objective To investigate the effect of Xingpikaiyu Formula(XF)on monoamine neurotransmitters in cortex and hippocampus of rat model of depression.Method The rat model of depression was established by using the methods of separation and chronic unpredictable stress.The changes of monoamine neurotransmitters and their metabolites in cortex and hippocampus were determined by HPLC_electrochemistry.Results Compared with the normal group,5_HT in cortex and hippocampus of the model group was obviously decreased.While the levels of DOPAC,HVA,DOPAC/DA,5_HIAA/5_HT of hippocampus and 5_HIAA/5_HT of cortex in the model group were higher significantly than that of the normal group.XF obviously increased 5_HT in cortex and hippocampus and decreased DOPAC and HVA in hippocampus.XF also decreased DOPAC/DA,5_HIAA/5_HT of hippocampus and 5_HIAA/5_HT of cortex.Conclusion XF has an anti_depression effect through inhibiting the metabolism of 5_HT and DA in cortex and hippocampus,and relatively increases the levels of 5_HT and DA in hippocampus and 5_HT in cortex.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2005年第3期55-57,共3页 Journal of Beijing University of Traditional Chinese Medicine
关键词 醒脾开郁方 抑郁模型 神经递质 5-羟色胺 高香草酸 多巴胺 Xingpikaiyu Formula depression model neurotransmitter 5_hydroxytryptamine homovanillic acid dopamine
  • 相关文献

参考文献4

二级参考文献25

  • 1张家俊,陈文为.中药酸枣仁、龙齿、石菖蒲对小鼠脑组织单胺类神经递质及其代谢物的影响[J].北京中医药大学学报,1995,18(6):64-66. 被引量:92
  • 2[1]Lieberinan JA. Mailman RB. Duncan G, et al. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry, 1998, 44 (10):1099~ 1117.
  • 3[2]Rubenstein JL. Development of serotonergic neurons and their projections. Biol Psychiatry, 1998,44(2): 145~ 149.
  • 4[3]Videbech P. MRI findings in patients with affective disorder:a meta-analysis. Acta Psychiat Scand, 1997,96(2): 157~168.
  • 5[4]Keefe RS. Silva SG. Perkins DO, et al. The effect of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and metaanalysis. Schizophrenia Bulletin. 1999,25 (2): 201 ~ 217.
  • 6[5]Leuchter AF. Cook JA. Uijtdehaage SH. et al. Brain structure and function and the outcomes of treatment for depression. J Clin Psychiatry,1997,58(Suppl, 16) :22~21.
  • 7[6]Diehl DJ, Gershon S. The role of dopamine in mood disorders. Comprehensive Psychiatry, 1992,33 ( 1 ): 115 ~ 120.
  • 8[7]Marek GJ. Aghajanian GK. The electrophysiology of prefrontal serotonin systems: theraputic implications for mood and psychosis. Biol Psychiatry, 1998,44(10): 1118~ 1127.
  • 9[8]Juckel G. Molnar M. Hegerl U, et al. Auditory-evoked potentials as indicator of brain serotonergic activity-first evidence in behaving cats. BiolPsychiatry, 1997,41 (10): 1181 ~ 1195.
  • 10[9]Young E,Korszun A. Psychoneuroendocrinology of depression:Hypothalamic-Pituitary-Gonadal Axis. Psychiat Clin North Am, 1998,21 (3): 309~323.

共引文献284

同被引文献365

引证文献20

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部